Job Description

Early Commercial Strategy Director, Respiratory Vaccines

As an Early Commercial Director, Respiratory Vaccines, you will play a strategic role and be a key member of the broader Global Vaccines Commercial Team. This position reports to a Senior Global Director, Commercial and Portfolio Strategy team, Global Vaccines Commercial group. The role will be based at one of GSK\xe2\x80\x99s major sites; Wavre BE, London UK, Philadelphia US, or Boston US with some flexibility in Europe or East Coast US on locations for the right candidate.

The Vaccine Commercial & Portfolio Strategy group core functions are:

Lead the development of the GSK Vaccines portfolio strategy Develop commercial evaluation of key assets within the GSK vaccine R&D pipeline, covering vaccines and associated targeted immunotherapy products Lead the commercial development of asset and therapy area strategies Build robust forecasts aligned to strategy and delivering assets through appropriate governance Support business development with commercial assessments

As the Early Commercial Director, Respiratory Vaccines your role is to develop & lead the early commercial strategy work that underpins co-created optimized Target Vaccine Profiles and vaccine forecast valuations. This work is required to secure GSK\xe2\x80\x99s confidence and enthusiasm to invest in continuing vaccine development to deliver competitive assets for future commercial success. In your role, you could be involved in a wide range of vaccines, across diseases, technology platforms and life cycle, from discovery to life cycle management, but the core focus of this role will be Respiratory.

Critical to the success of this position is an ability to demonstrate the value of strong commercial partnership with the R&D organization, whilst championing the need for patient, health care professional, recommending body and payer focus during early development. This role also requires the ability to build effective collaboration with our key markets (US, Japan, China, Germany) and regions to develop global strategy informed by and aligned with our stakeholders.

Key Responsibilities include, but are not limited to:

• Sit as a core member of early- and/or late-stage Vaccine Development Teams (VDTs) for GSK\xe2\x80\x99s Vaccine pipeline and lead the commercial activities within those assigned asset/s
• Develop credible, ambitious strategies for our candidate vaccines to meet future customer needs
• Estimate and validate commercial assumptions, developing robust, evidence-based global market and asset forecasts and valuations for pipeline vaccines as they progress through development milestones and governance decision points.
• Provide market landscapes and therapy area overviews and situation analyses to support strategy and trade off decisions associated with investment proposals
• Support your recommendations with appropriate competitive intelligence, customer insights, secondary data, market analogues or bespoke market research, showing creativity to build confidence and ambition for our assets, judgement to determine the level of validation needed, and maturity to manage time and budget to optimal effect.
• Interact extensively with the respective R&D project teams, priority markets, regional leads across the commercial, market access, S&O and medical organizations.
• Develop the analyses and identify the relevant customer insights to generate hypotheses
• Support the GVCPS leadership with development of portfolio strategy
• Support business development assessments on an ass needed basis

Why you?

Basic Qualifications:

We are looking for professionals with these required skills to achieve our goals:

• Bachelor\xe2\x80\x99s degree in science or business
• Significant number of years of relevant industry experience in healthcare; pharmaceutical (medical or marketing/sales background), management consultancy or financial institution with a thorough understanding of the vaccine/drug development and commercialization process (i.e., roles in early commercial, marketing, business development, insights and analytics, forecasting, pricing and market access, development, portfolio analytics)

Preferred Qualifications:

If you have the following characteristics, it would be a plus:

• Experience in the US Market
• Experience leading commercial function(s) within sizeable markets (e.g. BU head or Director, for functions including Sales, Marketing or Market Access)
• Experience in Vaccines
• MBA, or postgraduate studies in medicine, sciences, business and/or strategy
• Equity analyst experience with investment bank and/or PE or VC investment experience (deal origination etc.) Or medical scientist with investment decision experience in R&D.
• Corporate/Business Unit/Therapy Area/Brand strategy development experience, Early asset/clinical development experience, Portfolio analysis/analytics experience
• Credibility and proven experience of leadership in a cross-functional matrix environment
• Highly effective interpersonal skills and the ability to create strong working relationships across functions and geographies
• Highly effective communication at all levels of the organization, including the ability to challenge, inspire and influence
• Ability to work as an individual contributor, member and leader of a team
• Analytical skills and the ability to synthesize information from multiple data sources
• Strong prioritization and decision-making
• Ability to navigate complex business challenges
• Ability to independently identify and assess opportunities, mitigating risks and issues
• High-level of personal accountability and able to work independently to achieve objectives

Closing Date for Applications: 7th September 2023 (COB)

Please take a copy of the , as this will not be available post closure of the advert. When applying for this role, please use the \xe2\x80\x98cover letter\xe2\x80\x99 of the online application or your CV to describe how you meet the competencies for this role, as outlined in the job requirements above. The information that you have provided in your cover letter and CV will be used to assess your application.

Why GSK?

Why Us?

GSK is a global biopharma company with a special purpose \xe2\x80\x93 to unite science, technology and talent to get ahead of disease together \xe2\x80\x93 so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns \xe2\x80\x93 as an organization where people can thrive. Getting ahead means preventing disease as well as treating it, and we aim to positively impact the health of 2.5 billion people by the end of 2030.

Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it\xe2\x80\x99s also about making GSK a place where people can thrive. We want GSK to be a workplace where everyone can feel a sense of belonging and thrive as set out in our Equal and Inclusive Treatment of Employees policy. We\xe2\x80\x99re committed to being more proactive at all levels so that our workforce reflects the communities we work and hire in, and our GSK leadership reflects our GSK workforce.

As an Equal Opportunity Employer, we are open to all talent. In the US, we also adhere to Affirmative Action principles. This ensures that all qualified applicants will receive equal consideration for employment without regard to neurodiversity, race/ethnicity, colour, national origin, religion, gender, pregnancy, marital status, sexual orientation, gender identity/expression, age, disability, genetic information, military service, covered/protected veteran status or any other federal, state or local protected class*(*US only).

We believe in an agile working culture for all our roles. If flexibility is important to you, we encourage you to explore with our hiring team what the opportunities are.

Should you require any adjustments to our process to assist you in demonstrating your strengths and capabilities contact us on or 0808 234 4391. Please note should your enquiry not relate to adjustments, we will not be able to support you through these channels

As you apply, we will ask you to share some personal information which is entirely voluntary. We want to have an opportunity to consider a diverse pool of qualified candidates and this information will assist us in meeting that objective and in understanding how well we are doing against our inclusion and diversity ambitions. We would really appreciate it if you could take a few moments to complete it. Rest assured, Hiring Managers do not have access to this information and we will treat your information confidentially.

Important notice to Employment businesses/ Agencies

GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK\'s commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.

Please note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license, GSK may be required to capture and report expenses GSK incurs, on your behalf, in the event you are afforded an interview for employment. This capture of applicable transfers of value is necessary to ensure GSK\xe2\x80\x99s compliance to all federal and state US Transparency requirements. For more information, please visit GSK\xe2\x80\x99s Transparency Reporting site.

We\xe2\x80\x99re moving towards a more sustainable future with our new headquarters. With better public transport links and proximity to world-class science and technology institutions, we\xe2\x80\x99re excited for our move to the vicinity of Earnshaw Street, London WC1A (\xe2\x80\x9cthe New HQ\xe2\x80\x9d) by end H1 2024.

GlaxoSmithKline